Chile: Carlyle Group makes new offer for EMV – Founders ask for vote to be delayed
US-based investors The Carlyle Group have been outed as interested parties in snatching up the assets of healthcare chain Isapre-Masvida, creating a rift within the latter’s board, which was in advanced talks with rival Nexus.
Carlyle Group, which owns local companies Doggis, Juan Maestro and Mamut, has said it will formally communicate their offer to EMV’s directors, seeking to take over Masvida, Isapre and the entirety of their passive and active assets and clinics, with a value estimated at $150 bn pesos (approx. $232.4 million US), to be paid in cash.
The proposal arrives at a tense time for EMV’s board, which is divided over those who have pushed for the Nexus deal and board members from the Concepción region, who have not looked kindly on Nexus’ offer. This partly due to what they consider a low offer of $35 bn ($54 million US) for the Mas Vida affiliates portfolio, as well as for the short timetable and tight deadline given to respond and study the offer.
Full Content: Pulso
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI